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ta.2013.0Abstract Introduction: Hemangiopericytomas are rare, vascular neoplasms that are derived from
Zimmerman’s capillary pericytes. They are found most commonly in the retroperitoneum/pelvis
and lower extremities and are known to have malignant biological behavior. Of the paranasal
sinuses, ethmoid and sphenoid sinuses are most commonly involved.
Case Report: We report an uncommon case of a 77-year-old man, who presented with history of
nasal block, nasal discharge and epistaxis since 10 years. On examination, there was a ﬂeshy polyp-
oidal mass seen ﬁlling the entire right nasal cavity. CT scan of the osteomeatal complex revealed a
soft tissue density lesion occupying the entire right nasal cavity, projecting through the posterior
choanae into the nasopharynx. An endoscopic excision of the entire mass was done. Histopathol-
ogical examination and immunohistochemistry conﬁrmed the diagnosis of Hemangiopericytoma.
Discussion: Hemangiopericytoma is a rare vascular tumor. These lesions are more frequently
reported in the seventh decade of life, and the usual presentation includes epistaxis and nasal
obstruction. While corticosteroid use, hypertension and pregnancy have been proposed as etiolog-
ical factors in the development of HPC, this is not widely accepted. It exhibits low malignant poten-
tial and distant metastasis is exceedingly rare.
Conclusion: Hemangiopericytomas of the nasal cavity and paranasal sinuses exhibit low malig-
nant potential and distant metastasis. The treatment of choice is wide surgical resection which is the
only curative modality.
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Hemangiopericytomas (HPC) are rare, vascular neoplasms,
derived from Zimmerman’s capillary pericytes, which sur-
round all capillaries, and which account for 1% of all vascular
tumors.1 Initially described by Stout and Murray, they are
found most commonly in retroperitoneum/pelvis and lower
extremities and are known to have malignant behavior.
7.5–25% of all HPCs are found in the head and neck region,
with a marked tendency to occur in nasal cavity and paranasalgyptian Society of Ear, Nose, Throat and Allied Sciences.
Figure 2 Post operative specimen removed from the right nasal
cavity.
152 P.M. Kamath et al.sinuses.1,2 Of the paranasal sinuses, ethmoid and sphenoid
sinuses are most commonly involved. HPCs at these sites do
not have the same risk of malignancy and metastasis as HPCs
elsewhere.
Due to variation in histological and clinical features of sin-
onasal type hemangiopericytomas, compared with their soft
tissue counterparts, it is now widely accepted that these tumors
represent an independent clinical entity, referred to as glo-
mangiopericytoma, due to its similarity to glomus tumors.3
Effective management requires wide surgical excision with
clear resection margins, as these tumors are relatively radiore-
sistant. Recent advances in endoscopic surgery have led to the
development of techniques that now permits endoscopic
resection.
2. Case report
A 77 year old man presented to our service with history of nasal
block and nasal discharge since 10 years. He also had occa-
sional episodes of epistaxis and headache. He was a known case
of diabetes and hypertension on long term aspirin treatment.
On examination, there was a ﬂeshy polypoidal mass seen
ﬁlling the entire right nasal cavity, displacing the septum to
the left side. There was a minimal bleeding on touch. Postnasal
examination revealed the mass extending into the nasopharynx
through the right choanae.
A CT scan of the osteomeatal complex was performed,
which revealed a soft tissue density lesion occupying the entire
right nasal cavity, projecting through the posterior choanae
into the nasopharynx, deviating the septum to the left and
medial wall of the maxillary sinus to the right. The lesion
was superiorly displacing the ethmoid sinus laterally and
extending to the cribriform plate (Fig. 1).
The patient was posted for surgery and an endoscopic exci-
sion of the lesion was done. The lesion was initially mobilizedFigure 1 CT scan showingmass ﬁlling the entire right nasal cavity
and displacing the septum and medial wall of maxillary sinus.
Figure 3 Follow Up sinoscopy showing nasal cavity to be free of
growth.from the nasopharynx into the nasal cavity and debulking was
done. Following this sinoscope was passed. The lesion was
seen to be arising from the sphenoethmoidal region. Endo-
scopic excision of the mass was carried out. The right
maxillary sinus ostium was widened and sinus was ﬁlled with
purulent discharge. Mass was completely removed from the
ethmoidal and sphenoid region (Figs. 2 and 3).
Figure 4 Spindle shaped tumor cells are seen in sheets and
whorls around vascular channel. (H and E-45·).
Figure 5 IHC–smooth muscle actin is strongly positive in tumor
cells.
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vealed tumor cells seen arranged in interlacing fascicles sepa-
rated by dilated and irregularly shaped branching blood
vessels. Cells had oval vesicular to elongated hyperchromatic
nuclei with indistinct cytoplasmic borders. Mitosis was <2/
10 HPF. Reticulin stain showed tumor cells proliferating
around the blood vessels. IHC markers were done for conﬁr-
mation of the diagnosis. SMA (smooth muscle actin) was
strongly positive, while CD34 was focally positive. S100 and
CD99 were negative. Diagnosis of Hemangiopericytoma was
conﬁrmed (Figs. 4 and 5).
3. Discussion
Hemangiopericytoma is a rare vascular tumor occurring
anywhere in the body, but more commonly involves the soft
tissues of trunk and lower extremities. Approximately 15%
of all soft tissue HPCs occur in the head and neck region,
mainly in the nasal cavity and paranasal sinuses. These lesionsare more frequently reported in the seventh decade of life, and
the usual presentation includes epistaxis and nasal obstruction.
While corticosteroid use, hypertension and pregnancy have
been proposed as etiological factors in the development of
HPC, this is not widely accepted.4
Diagnosis depends ﬁrstly on thorough endoscopic evalua-
tion and secondly on imaging techniques including CT and
MRI. The characteristic ﬁndings on CT include a soft tissue
mass with enhancement following the administration of intra-
venous contrast, and gadolinium contrast in case of MRI scan-
ning.5 The role of routine angiography in the management of
HPC is not clearly deﬁned. However its use is advocated for
pre-operative planning and embolization, which in turn signif-
icantly reduces the risk of intraoperative hemorrhage.6,7
From a histological viewpoint, an accepted deﬁnition and
classiﬁcation of HPC do not exist. Several authors have ad-
dressed the histologic grading of HPC as benign, borderline,
low grade malignant and overtly malignant.8 The histological
features of HPC consist of uniform, spindle-shaped cells with
indistinct cytoplasm and large nuclei, distributed around vas-
cular channels, typically exhibiting a stag horn branching pat-
tern. The vascular channels are often more readily deﬁned
following reticulin staining.
However, since its initial description the characteristic his-
tological features in HPCs have been found to be non-speciﬁc
and encountered in up to 15% of unrelated soft tissue neo-
plasms. In the 2005 World Health Organization classiﬁcation
of head and neck tumors, it was recommended that sinona-
sal-type HPC be referred to as glomangiopericytoma, in light
of the similarity with glomus tumor.9
Immunohistochemically, the HPC cells are invariably posi-
tive for Vimentin, SMA but very rarely and only focally for
smooth muscle markers such as desmin. A sub-population of
tumor cells is also immunoreactive for factor XIIIa and histo-
compatibility antigen HLA-DR. CD34 usually stains only
endothelial cell component, although sometimes there is a dif-
fusion effect in the immediate vicinity.10
The treatment of choice is wide surgical resection which is
the only curative modality. There has been an increasing usage
of endoscopic resection techniques for sinonasal HPC because
of its slow expansile growth which produces smooth instead of
inﬁltrative tumor borders. Endoscope allows a magniﬁed view
and therefore accurate assessment of the site of origin and rela-
tion to surrounding structures. Also, it preserves the nasal
physiologic function and avoids a large external incision. Fac-
tors that not favorable include septal deviation, tumors which
are large or highly vascular, intracranial extension, orbit or the
pterygopalatine fossa involvement. Therefore, patients have to
be stringently assessed and selected.
The reported recurrence rate of HPC is quite varied, rang-
ing from 7% to 20%, with an average time of recurrence of 6–
7 years.2 While an incomplete primary excision has been iden-
tiﬁed as the primary factor in recurrent disease, severe nuclear
pleomorphism, osseous invasion, large tumor size (more than
5 cm) and a high mitotic to proliferation rate also appear to
signiﬁcantly increase the risk of recurrence.
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